In this episode of The DTC Insider, Brian Roisentul sits down with Lekha Vyas, founder of SynQ Wellness, to talk about one of the most talked about trends in health right now: GLP-1 and what comes next.

From her background leading brands at companies like L’Oréal and Estée Lauder to building a new category in wellness, Lekha shares how she’s developing a plant-based alternative to GLP-1 drugs, delivered through a Listerine style strip that dissolves in your mouth.

They dive into the real impact of GLP-1 drugs, including long term side effects, dependency, and why more consumers are starting to question them.

Lekha also explains the science behind sublingual delivery, how it bypasses the gut, and why it could change the future of supplements and metabolic health.

Plus, she breaks down what it actually takes to build a breakthrough product, from 75+ formula iterations to early human testing, and how she’s approaching go to market, TikTok, and DTC in a hyper competitive landscape.

--

This episode is brought to you by BSR.

BSR helps 7-figure+ brands build and optimize strategic growth systems that unlock hidden revenue and scale profitably, without adding chaos, channels, or unnecessary spend.

To learn more about BSR, visit their website or book a call.